This study will last up to 62 weeks. You will visit the clinic up to 17 times. Certain clinic
visits will include physical examination, medical history review and lung function tests. The
purpose of this study is to see if one asthma drug (fluticasone propionate/salmeterol) is
better in reducing the number of asthma exacerbations compared with another drug (fluticasone
propionate alone)
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate Xhance